Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMX-IN-1 (BMX kinase inhibitor) is a selective inhibitor of bone marrow tyrosine kinase on chromosome X (BMX, IC50 = 8 nM) and the related Bruton’s tyrosine kinase (BTK, IC50 = 10.4 nM), but BMX-IN-1 is more than 47-656 fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.
説明 | BMX-IN-1 (BMX kinase inhibitor) is a selective inhibitor of bone marrow tyrosine kinase on chromosome X (BMX, IC50 = 8 nM) and the related Bruton’s tyrosine kinase (BTK, IC50 = 10.4 nM), but BMX-IN-1 is more than 47-656 fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity. |
ターゲット&IC50 | BTK:10.4 nM, BMX:8 nM |
別名 | BMX kinase inhibitor |
分子量 | 524.59 |
分子式 | C29H24N4O4S |
CAS No. | 1431525-23-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: 9 mg/mL (17.16 mM), Sonication is recommended.
DMSO: 8 mg/mL (15.25 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMX-IN-1 1431525-23-3 Angiogenesis Tyrosine Kinase/Adaptors BTK BMX kinase inhibitor inhibit BMX Kinase BMX IN 1 Bruton tyrosine kinase Btk Inhibitor BMXIN1 inhibitor